Skip to main content
CRMD
NASDAQ Life Sciences

Court Affirms CorMedix Patents for Mincin Valid, Infringed by Nexus Pharma

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$8.43
Mkt Cap
$655.858M
52W Low
$6.125
52W High
$17.43
52W Position info
38% above low
Off High info
52% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CRMD sits 38% above its 52-week low of $6.125.

Summary

A court has affirmed the validity of CorMedix's patents covering its Mincin for Injection product and ruled that Nexus Pharmaceuticals' competing product infringes on them. This is a significant legal victory for CorMedix, protecting its intellectual property and market exclusivity for a key asset. The decision removes a competitive threat and secures potential future revenue streams for the company.

At the time of this announcement, CRMD was trading at $8.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $655.9M. The 52-week trading range was $6.13 to $17.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CRMD - Latest Insights

CRMD
Nov 02, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $5.74 info
Change: +$0.240 (+4%) info
Market Cap: $441.165M info
CRMD
Nov 02, 2026, 7:32 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.62
Real-time Price: $5.74 info
Change: +$0.1245 (+2%) info
Market Cap: $441.165M info
CRMD
Oct 19, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.45
Real-time Price: $5.74 info
Change: -$1.71 (-23%) info
Market Cap: $441.165M info
CRMD
Aug 13, 2026, 8:07 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.65
Real-time Price: $5.74 info
Change: -$1.91 (-25%) info
Market Cap: $441.165M info
CRMD
Aug 13, 2026, 7:44 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.65
Real-time Price: $5.74 info
Change: -$1.91 (-25%) info
Market Cap: $441.165M info